Sign in
4

Changes in Ownership

Enveric Biosciences, Inc. Filed Acc 0000921895-18-002601

Options or other derivatives

  • Chief Financial Officer acquired 200,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Patel Viraj J Chief Financial Officer 2018-09-12 Grant or award · Option (Right to Buy) +200,000 200,000 D
Loading xslF345X03/form410211002pat_09142018.xml…